These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. Saletu MT; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Nosiska D; Zeitlhofer J; Saletu B Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):20-32. PubMed ID: 15538594 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers. Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ Int J Clin Pharmacol Res; 1989; 9(3):183-95. PubMed ID: 2568348 [TBL] [Abstract][Full Text] [Related]
10. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. Swanson JM; Greenhill LL; Lopez FA; Sedillo A; Earl CQ; Jiang JG; Biederman J J Clin Psychiatry; 2006 Jan; 67(1):137-47. PubMed ID: 16426100 [TBL] [Abstract][Full Text] [Related]
12. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500 [TBL] [Abstract][Full Text] [Related]
13. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772 [TBL] [Abstract][Full Text] [Related]
16. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
17. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Pack AI; Black JE; Schwartz JR; Matheson JK Am J Respir Crit Care Med; 2001 Nov; 164(9):1675-81. PubMed ID: 11719309 [TBL] [Abstract][Full Text] [Related]
18. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Black JE; Hirshkowitz M Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291 [TBL] [Abstract][Full Text] [Related]
19. Modafinil and nicotine interactions in abstinent smokers. Sofuoglu M; Waters AJ; Mooney M Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195 [TBL] [Abstract][Full Text] [Related]
20. Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial. Joos L; Goudriaan AE; Schmaal L; Fransen E; van den Brink W; Sabbe BG; Dom G Eur Neuropsychopharmacol; 2013 Aug; 23(8):948-55. PubMed ID: 23141152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]